AzTrials
AzTrials

StrokeNCT07119632

Study of Medicine Stick Therapy Combined With Repeated Urotong Herapy on Lower Limb Dysfunction in Stroke Patients

A study testing RFE therapy in people with Stroke, run by Jiangen Ye.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

At present, domestic scholars have applied medicine stick therapy and repetitive facial exercise (RFE) to the rehabilitation treatment of stroke patients, but there are few relevant literature reports on medicine stick therapy combined with RFE and show the differences in the effects of the two different treatment… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Stroke
What is being tested?
RFE therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7 participants
Where
No sites listed yet
Study dates
1 Sep 2025to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinical diagnosis of stroke
  • The first onset and the disease duration must be less than 3 months. exclusion criteria:
  • Combined with other serious diseases such as severe cardiovascular, respiratory failure, liver and renal function damage, malignant tumors, etc.
  • Consciousness disorders and cognitive impairment;
  • Eczema, inflammation, infection, and scars at acupuncture points or skin;

Who cannot join

None listed.

About this study

Official title: Clinical Study Plan of Medicine Stick Therapy Combined With Repeated Urotong Therapy on Lower Limb Dysfunction in Patients With Stroke

At present, domestic scholars have applied medicine stick therapy and repetitive facial exercise (RFE) to the rehabilitation treatment of stroke patients, but there are few relevant literature reports on medicine stick therapy combined with RFE and show the differences in the effects of the two different treatment methods. To this end, this study intends to follow up the effects and effects of drug stick therapy and its combined effect with RFE on the recovery of lower limb motor function in patients after stroke, and follow up the patients' limb motor function, daily life activity ability, quality of life, balance function, etc.

Read the detailed description

At present, domestic scholars have applied medicine stick therapy and repetitive facial exercise (RFE) to the rehabilitation treatment of stroke patients, but there are few relevant literature reports on medicine stick therapy combined with RFE and show the differences in the effects of the two different treatment methods. To this end, this study intends to follow up the effects and effects of drug stick therapy and its combined effect with RFE on the recovery of lower limb motor function in patients after stroke, and follow up the patients' limb motor function, daily life activity ability, quality of life, balance function, etc.; use the Fugl-Meyer motor function evaluation scale, Barthel index, Brunnstrom grading, Holden walking function and other scales to conduct multi-angle evaluation of stroke patients, combine traditional Chinese medicine rehabilitation with Western medicine rehabilitation treatment, combine these two different treatment technologies, give full play to their respective advantages and integrated effects to verify. The specific research content includes: participant recruitment and screening, random grouping design, baseline evaluation, treatment intervention, post-treatment evaluation, data statistics and analysis. This study aims to explore the feasibility and advantages of the combined application of drug stick therapy combined with RFE to provide more effective treatment methods for rehabilitation of stroke patients.

Conditions
Stroke
Being tested
RFE therapy
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RFE therapyOther

Study groups in NCT07119632
Study groupRoleWhat they receive
Medication stick therapy +Repetitive facilitative exerciseExperimental1. Medication stick therapy:The specific operation is as follows: The patient lies down, holds the rods with both hands, and massages and squeezes the muscles from the muscle end towards the starting end while applying the medicinal wine. This causes the muscles to contract in a centripetal direction. The treatment is considered successful when there is local heat and the skin becomes flushed. It is performed 20 minutes per time, once a day, 6 times a week, for a total of 6 weeks. 2. Repetitive facilitative exercise: It includes specific movement patterns of the affected lower limb and weight-bearing training on the healthy side.Each movement pattern is performed 100 repetitions with the therapist's assistance, once a day, 6 days a week, for a total of 6 weeks of continuous treatment.
Receives: Other: RFE therapy
Repetitive facilitative exerciseActive comparatorRepetitive facilitative exercise: It includes specific movement patterns of the affected lower limb and weight-bearing training on the healthy side.Each movement pattern is performed 100 repetitions with the therapist's assistance, once a day, 6 days a week, for a total of 6 weeks of continuous treatment.
Receives: Other: RFE therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Modified Barthel Index

    The Modified Barthel Index has a minimum score of 0 and a maximum score of 100. The higher the score, the better the functional ability.

    Measured: From enrollment to 8 weeks of treatment

Secondary outcomes (1)
  1. Holden Walking Function

    Holden Walking Function: Minimum level 0, maximum level 6. The higher the level, the better the function.

    Measured: From enrollment to 8 weeks of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
7 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07119632
Sponsor's protocol ID
2024B0564
Status last verified
Aug 2025
First submitted
9 Jul 2025
Last updated
13 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing RFE therapy in people with Stroke, run by Jiangen Ye.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Modified Barthel Index (time frame: From enrollment to 8 weeks of treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in